Progenics Follow Verify

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

http://www.progenics.com
Type	Public
Founded	1988
Headquarters	New York, New York
Number of employees	51-200 employees

Top 5 Recent Tweets

Date	Author	Comment
April 20, 2021	BWayynne	@CoronaTurd Yeah was being generous there by limiting it to the time it was under CYDY control. Story for another d… https://t.co/H3b1h589pq
April 16, 2021	ProgenicsCB	When you choose Progenics, you can get the most out of your #cordblood. We have always successfully generated a hig… https://t.co/rTZYlEaqe8
April 07, 2021	urotoday	The biology of #ProstateCancer metastasis and what #PSMAImaging is teaching us. Presentation by @pienta_brady… https://t.co/i0A8mDZR78

Top 5 Lifetime News Headlines

Top Authors

• Cherry Ann Baluyut
• Chithma Kalansuriya
• Afaf Abdallah
• View all authors

Verification history

• 596 days ago


• 868 days ago


• 868 days ago


• View all verifications